![Ronald M. Nelson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald M. Nelson
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
John Erb | M | 75 |
IntraTherapeutics, Inc.
![]() IntraTherapeutics, Inc. Medical SpecialtiesHealth Technology IntraTherapeutics, Inc. develops minimally invasive devices for diagnosis and treatment of diseased blood vessels. The company is headquartered in St. Paul, MN. | 4 anni |
John J. O'Mahony | M | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
David B. Springer | M | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Barry Michaels | M | 74 |
IntraTherapeutics, Inc.
![]() IntraTherapeutics, Inc. Medical SpecialtiesHealth Technology IntraTherapeutics, Inc. develops minimally invasive devices for diagnosis and treatment of diseased blood vessels. The company is headquartered in St. Paul, MN. | 1 anni |
Stephen M. Campe | M | 59 |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Kurt C. Wheeler | M | 71 |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
James M. Garvey | M | 77 |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Howard R. Levin | M | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | 13 anni |
Steven Brandt | M | 68 |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | 2 anni |
Ashley Friedman | M | 46 |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
John R. Wigneswaran | M | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Ed Rychlick | M | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Debbie Stephens Ledet | F | - |
CHF Solutions, Inc. /Old/
![]() CHF Solutions, Inc. /Old/ Medical SpecialtiesHealth Technology CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 13 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ronald M. Nelson
- Contatti personali